60561-72-0

Usage

Uses

Used in Pharmaceutical Industry:
[(4-methylphenyl)amino](phenyl)acetic acid is used as an anti-inflammatory agent for the treatment of conditions involving pain and inflammation, such as menstrual pain, rheumatoid arthritis, and other similar conditions. It is effective in reducing the production of prostaglandins, which are the primary cause of pain and inflammation.
Used in Pain Management:
[(4-methylphenyl)amino](phenyl)acetic acid is used as a pain reliever to alleviate discomfort associated with various conditions, including menstrual pain and arthritis. Its ability to inhibit prostaglandin production makes it a useful option for managing pain.
Used in Oral Medication:
[(4-methylphenyl)amino](phenyl)acetic acid is used as an active ingredient in various forms of oral medication, such as tablets and capsules, for easy administration and absorption by the body.

Upstream product

• 540-23-8 p-toluidine hydrochloride 
• 100-52-7 benzaldehyde 
• 106-49-0 p-toluidine 
• 62708-42-3 o-allylbenzaldehyde 
• 104-94-9 4-methoxy-aniline 
• 124-38-9 carbon dioxide 
• 2272-45-9 benzal-p-toluidine 
• 4870-65-9 2-bromophenylacetic acid 
• 7647-01-0 hydrogenchloride 
• 75619-96-4 2,5-diphenyl-1-p-tolyl-1,5-dihydro-imidazol-4-one 
• 75619-99-7 2,5-diphenyl-1-p-toluidino-imidazolidin-4-one 

Downstream Products

• 1233329-20-8 4-methyl-phenyl-amino-phenyl-acetic acid (R)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester 
• 68150-36-7 7-diethylamino-6-methyl-4-phenyl-3-p-tolyl-2,2-bis-trifluoromethyl-3,4-dihydro-2H-[1,3]oxazepin-5-one 
• 68150-24-3 4-phenyl-3-p-tolyl-2,2-bis-trifluoromethyl-oxazolidin-5-one 
• 3815-77-8 4-phenyl-3-p-tolylsydnone 

Relevant academic research and scientific papers

A synthesis of α-amino acids via direct reductive carboxylation of imines with carbon dioxide

A method for the synthesis of α-amino acids by direct reductive carboxylation of aromatic imines with CO2 is described. The protocol employs readily available commercial reagents and serves as a one-step alternative to the Strecker synthesis. The Royal Society of Chemistry 2013.

ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF

The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, to methods of preparing such derivatives, to compositions comprising them and therapeutic use thereof.

Synthesis of Some New 3,4-Diarylsydnones

The synthesis of some new sydnones 4 is described.Their characteristic absorption maxima, mass spectroscopic fragmentation and C=O-valence vibrations are given.The sydnones 4 are synthezid by nitrosation of C,N-diarylglycines 3 (from strecker synthesis) a